Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00237042 · ClinicalTrials.gov registry record · NA
Managing Temporomandibular Disorder (TMD) Symptoms
A NA study of Temporomandibular Joint Disorders, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 252
- Enrollment target
- 1
- Study location
NCT00237042 is a NA study of Temporomandibular Joint Disorders that has completed, run by University of Washington. The registered enrollment target is 252 participants, below the 373-participant average among 3 other Temporomandibular Joint Disorders trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00237042, a NA study of Temporomandibular Joint Disorders, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether treatments targeted to the hormonal factors and the cyclicity of TMD symptoms associated with the menstrual cycle are more effective in relieving TMD pain and symptoms than standard self management treatment.
Conditions Studied
Interventions
- BEHAVIORAL Self Management
- BEHAVIORAL Targeted Self Management
- DRUG 20 mcg ethinyl estradiol and 100 mcg levonorgestrel
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2005-10 |
| Est. Completion | 2010-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00237042
The ClinicalTrials.gov registry entry for NCT00237042 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 373-participant average among 3 other Temporomandibular Joint Disorders trials with a reported enrollment target (32% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Temporomandibular Joint Disorders appearing as the primary indexed condition, and to 3 interventions - of which Self Management is the first listed.
NCT00237042 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT00237042 about?
NCT00237042 is a clinical study titled "Managing Temporomandibular Disorder (TMD) Symptoms". The purpose of this study is to determine whether treatments targeted to the hormonal factors and the cyclicity of TMD symptoms associated with the menstrual cycle are more effective in relieving TMD pain and symptoms than standard self management treatment.
What is the current status of trial NCT00237042?
This trial is currently completed. It is a NA study. The enrollment target is 252 participants. The study started on 2005-10. Estimated completion is 2010-06.
What conditions does trial NCT00237042 study?
This clinical trial studies the following conditions: Temporomandibular Joint Disorders.
What interventions are being tested in trial NCT00237042?
The interventions under investigation include: Self Management (BEHAVIORAL), Targeted Self Management (BEHAVIORAL), 20 mcg ethinyl estradiol and 100 mcg levonorgestrel (DRUG).
Who is sponsoring clinical trial NCT00237042?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00237042 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Temporomandibular Joint Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.